Results 11 to 20 of about 2,380 (175)
Moxidectin as an Endectocide in Reindeer [PDF]
Acta Veterinaria Scandinavica, 1998 During the winter 1991-92, 42 reindeer hinds of the Kaamanen Experimental Reindeer Herd in Finnish Lapland, naturally infected with various parasites, were allocated to 3 groups. One group was an untreated control group and the other 2 groups received either moxidectin or ivermectin at a dose of 200 micrograms kg-1 subcutaneously.
A, Oksanen, M, Nieminen
openaire +2 more sources
Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial. [PDF]
PLoS Neglected Tropical Diseases, 2016 BACKGROUND:Schistosomiasis affects millions of people, yet treatment options are limited. The antimalarial Synriam (piperaquine 150 mg/arterolane 750 mg) and the anthelminthic moxidectin revealed promising antischistosomal properties in preclinical or ...
Beatrice Barda +5 more
doaj +1 more source
Frontiers in Veterinary Science, 2021 Background: Heartworm disease (HWD) is a potentially fatal condition caused by the nematode Dirofilaria immitis. It is endemic in North America, and the American Heartworm Society recommends that owned dogs be on a Food and Drug Administration-approved ...
Kennedy Mwacalimba +6 more
doaj +1 more source
Parasites & Vectors, 2017 Background Monthly topical and sustained-release injectable formulations of moxidectin are currently marketed; however, an oral formulation, while approved at a dose of 3 μg/kg, is not currently marketed in the United States.
Tom L. McTier +7 more
doaj +1 more source
PLoS ONE, 2022 Formulations of macrocyclic lactone anthelmintics such as moxidectin are regularly administered to sheep to combat parasites. A disadvantage of these pharmaceuticals are their side effects on non-target organisms when entering the environment.
Carsten Eichberg +4 more
doaj +3 more sources
Parasites & Vectors, 2011 Background Two studies were conducted to evaluate and compare the efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 flea strain infesting cats.
Dryden Michael W +3 more
doaj +1 more source
Parasites & Vectors, 2020 Background Recent reports indicated that increasing the monthly oral dosage and the number of consecutive monthly doses of moxidectin improved the efficacy against macrocyclic lactone (ML)-resistant Dirofilaria immitis.
Kristina Kryda +6 more
doaj +1 more source
Effectiveness of Anthelmintic Treatments in Small Ruminants in Germany
Animals, 2022 Widespread anthelmintic resistance is a concern for small ruminant health and production worldwide. The current situation regarding anthelmintic efficacy is, however, not very well studied in Germany.
Katja Voigt +5 more
doaj +1 more source
Elimination of Dirofilaria immitis Infection in Dogs, Linosa Island, Italy, 2020–2022
Emerging Infectious Diseases, 2023 On Linosa Island, Italy, Dirofilaria immitis infection has been hyperendemic in dogs and seroprevalent among islanders. In 2020, we implemented a heartworm disease elimination program on Linosa Island. Of 54 dogs tested for D.
Emanuele Brianti +9 more
doaj +1 more source
Российский паразитологический журнал, 2022 The purpose of the research is to study acute oral toxicity in mice, and acute dermal and subchronic toxicity in rats of multicomponent antiparasitic Insacar Total C Plus (for dogs) and Insacar Total K Plus (for cats).Materials and methods.
N. V. Makhvatova
doaj +1 more source